IDiyas

For the Inventor, By the Inventor

Suita, Japan

Masayuki Muroi

USPTO Granted Patents = 13

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 68(Granted Patents)


Location History:

  • Naganohigashi, JP (1981)
  • Osaka, JP (1989 - 1990)
  • Suita, JP (1981 - 1993)

Company Filing History:

goldMedal13 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1981-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5196564 - Physiologically active substance TAN-931, its derivatives, their (1993-03-23),
2. 5147860 - TAN-1120, its derivatives, production and use thereof (1992-09-15),
3. 5013757 - Physiologically active substance Tan-931, its derivatives, their (1991-05-07),
4. 4963581 - Naphthopyran derivatives and use thereof (1990-10-16),
5. 4935543 - Physiologically active substance tan-931, its derivatives, their (1990-06-19),
6. 4803275 - 2-oxo-5-methyl-6-[4-heptene]-2H-pyrano[3,2-c]pyridine (1989-02-07),
7. 4540517 - Antibiotic TAN-420 (1985-09-10),
8. 4512975 - Macbecin derivatives and their production (1985-04-23),
9. 4421688 - Macbecin derivatives (1983-12-20),
10. 4421687 - Macbecin derivatives (1983-12-20),
11. 4373028 - Culture of Nocardia ATCC 31309 (1983-02-08),
12. 4298600 - Antibiotic C-14482 A.sub.1 and method for producing same (1981-11-03),
13. 4292309 - Antibiotics C-14482 B.sub.1, B.sub.2 and B.sub.3 (1981-09-29),

Title: **Masayuki Muroi: Innovator in Pharmaceuticals**

Introduction

Masayuki Muroi is a prominent inventor based in Suita, Japan, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 13 patents, Muroi’s innovative work has focused primarily on compounds that play pivotal roles in disease prevention and treatment.

Latest Patents

Among his latest patents is that of a physiologically active substance, TAN-931, along with its derivatives. This novel compound, characterized by a specific formula, serves as an aromatase inhibitor and includes processes for its production. Another notable invention is TAN-1120, which has the capability to inhibit angiogenesis, making it useful for the prophylaxis and therapy of various diseases, particularly those associated with tumor growth.

Career Highlights

Muroi’s career has been marked by his role at Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His drive for innovation continues to contribute to vital advancements in medical treatments and therapies.

Collaborations

Throughout his career, Masayuki Muroi has collaborated with esteemed colleagues such as Seiichi Tanida and Tsuneo Kanamaru, enhancing the scope and impact of their joint research endeavors in the pharmaceutical field.

Conclusion

Masayuki Muroi stands out as a dedicated inventor, whose patented innovations are paving the way for new therapeutic solutions. His contributions reflect a profound commitment to improving human health through science and creativity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…